AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 68 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 341 | -98.0% | 0.00% | – |
| Q1 2022 | $39,000 | -51.9% | 17,041 | 0.0% | 0.00% | – |
| Q4 2021 | $81,000 | -40.4% | 17,041 | -0.2% | 0.00% | – |
| Q3 2021 | $136,000 | -37.9% | 17,079 | -45.8% | 0.00% | – |
| Q2 2021 | $219,000 | -11.0% | 31,484 | +1.2% | 0.00% | – |
| Q1 2021 | $246,000 | +0.4% | 31,100 | 0.0% | 0.00% | – |
| Q4 2020 | $245,000 | -9.9% | 31,100 | -19.0% | 0.00% | – |
| Q3 2020 | $272,000 | -23.4% | 38,400 | 0.0% | 0.00% | – |
| Q2 2020 | $355,000 | +303.4% | 38,400 | +103.2% | 0.00% | – |
| Q1 2020 | $88,000 | -38.9% | 18,900 | 0.0% | 0.00% | – |
| Q4 2019 | $144,000 | -29.8% | 18,900 | -29.2% | 0.00% | – |
| Q3 2019 | $205,000 | +11.4% | 26,700 | -0.4% | 0.00% | – |
| Q2 2019 | $184,000 | +166.7% | 26,800 | +211.6% | 0.00% | – |
| Q1 2019 | $69,000 | +7.8% | 8,600 | 0.0% | 0.00% | – |
| Q4 2018 | $64,000 | -22.0% | 8,600 | 0.0% | 0.00% | – |
| Q3 2018 | $82,000 | -57.1% | 8,600 | -52.5% | 0.00% | – |
| Q2 2018 | $191,000 | – | 18,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 279,678 | $2,587,000 | 10.00% |
| Aisling Capital Management LP | 1,691,151 | $15,643,000 | 5.97% |
| Samsara BioCapital, LLC | 967,500 | $8,949,000 | 2.88% |
| Bain Capital Life Sciences Investors, LLC | 2,700,000 | $24,975,000 | 2.62% |
| Soleus Capital Management, L.P. | 369,852 | $3,421,000 | 1.95% |
| Nantahala Capital Management | 3,204,830 | $29,645,000 | 0.89% |
| Lion Point Capital, LP | 300,000 | $2,775,000 | 0.67% |
| Abingworth LLP | 240,500 | $2,221,000 | 0.62% |
| Sio Capital Management, LLC | 211,104 | $1,953,000 | 0.57% |
| Orbimed Advisors | 4,015,524 | $37,144,000 | 0.52% |